BIOREM Inc.
BRM.V
TSX
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | 118.64% | -89.85% | -92.87% | 328.47% | 456.81% |
Total Depreciation and Amortization | 44.24% | 71.61% | -30.89% | 271.98% | 33.74% |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 77.32% | -61.03% | -193.68% | 274.65% | 364.39% |
Change in Net Operating Assets | 0.16% | 16.62% | 55.61% | -106.85% | 18.68% |
Cash from Operations | 30.36% | 5.57% | -4,380.85% | 18.67% | 40.08% |
Capital Expenditure | -6,566.67% | 76.49% | -104.17% | 100.00% | 99.00% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -- | -- | -- | -- | -- |
Cash from Investing | -6,566.67% | 76.49% | -104.17% | 100.00% | 99.00% |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -10.06% | 9.49% | -32.79% | 79.06% | -2.78% |
Issuance of Common Stock | -- | -- | -- | -- | -- |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | -8.77% | 14.98% | 127.20% | 85.06% | -951.37% |
Foreign Exchange rate Adjustments | -332.46% | -143.60% | -150.53% | 337.36% | -79.04% |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 3.73% | 14.16% | -2,095.08% | 315.52% | 36.94% |